CLABSI Rates in Immunocompromised Patients: A Valuable Patient Centered Outcome?
CLABSI Rates in Immunocompromised Patients: A Valuable Patient Centered Outcome?
复制标题
DOI：
10.1093/cid/cir200
复制
发表时间：
2011-06-01
影响因子：
11.8
通讯作者：
Gordon, Steven M.
中科院分区：
文献类型：
--
作者：
Fraser, Thomas G.;Gordon, Steven M.
监测中心静脉导管所致医院获得性血流感染（HABSI）的公认方法需要使用国家健康与安全网络（NHSN）对导管相关血流感染（CLABSI）的定义。在这篇评论中，我们讨论了我们的经验与应用当前的NHSN监测定义的CLABSI和影响，公共报告的CLABSI率在设置一个高患病率的特殊人群感染预防（IP）计划。为了使IP计划能够满足其组织的持续改进需求，监测方法需要准确地捕获具有固有感染风险的免疫功能低下个体中可预防的HABSI的负担。目前的NHSN CLABSI定义缺乏对复杂和异质性患者人群的特异性，需要修改。除了定义之外，IP项目必须严格评估其当前监测方法的价值，以确保以患者为中心的结果是预防工作的重点。
The accepted approach to surveillance for hospital-acquired bloodstream infection (HABSI) due to central venous catheters requires use of the National Health and Safety Network (NHSN) definition for catheter-associated bloodstream infection (CLABSI). In this commentary, we discuss our experience with the application of current NHSN surveillance definitions for CLABSI and the impact that public reporting of CLABSI rates in settings with a high prevalence of special populations has on infection prevention (IP) programs. For IP programs to serve the continuous improvement needs of their organizations, surveillance methodologies need to accurately capture the burden of preventable HABSI among immunocompromised individuals with inherent risk for infection. Current NHSN CLABSI definitions lack specificity for complex and heterogeneous patient populations and require modification. Beyond definitions, IP programs must critically assess the value of their current approach to surveillance to assure that patient-centered outcomes are the focus of prevention efforts.